Kevin Esvelt and Jonas Sandbrink on risks from biological research

Abstract

Building on the lessons of the global COVID-19 pandemic, this conversation explores ways to mitigate the catastrophic risks posed by advanced biotechnology in the near future. Considering the interconnected and rapidly evolving nature of biological threats, the dialogue emphasizes the principles of risk reduction through diverse strategies. The experts discuss the concept of differential technological development, advocating for prioritizing the advancement of less risky technologies over higher risk counterparts. They propose a pandemic Test Ban Treaty as a potential mechanism to regulate risky research while maintaining scientific progress. The discussion also addresses the importance of deploying a layered defense system encompassing early detection of threats through meta-genomic sequencing, rapid response capabilities, protective technologies like advanced PPE and Far-UVC lighting, and the development of broad-spectrum medical countermeasures. Additionally, the need for comprehensive international cooperation, public engagement, and responsible access to genetic information is highlighted. The dialogue concludes by underscoring the urgency of addressing these risks and the shared responsibility of the scientific community, policymakers, and the general public in ensuring a safer future. – AI-generated abstract.